These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 34583232)
21. HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas. Jäger D; Barth TFE; Brüderlein S; Scheuerle A; Rinner B; von Witzleben A; Lechel A; Meyer P; Mayer-Steinacker R; Baer AV; Schultheiss M; Wirtz CR; Möller P; Mellert K Sci Rep; 2017 May; 7(1):2032. PubMed ID: 28515451 [TBL] [Abstract][Full Text] [Related]
22. Establishment and genomic characterization of the new chordoma cell line Chor-IN-1. Bosotti R; Magnaghi P; Di Bella S; Cozzi L; Cusi C; Bozzi F; Beltrami N; Carapezza G; Ballinari D; Amboldi N; Lupi R; Somaschini A; Raddrizzani L; Salom B; Galvani A; Stacchiotti S; Tamborini E; Isacchi A Sci Rep; 2017 Aug; 7(1):9226. PubMed ID: 28835717 [TBL] [Abstract][Full Text] [Related]
23. Brachyury gene copy number gain and activation of the PI3K/Akt pathway: association with upregulation of oncogenic Brachyury expression in skull base chordoma. Otani R; Mukasa A; Shin M; Omata M; Takayanagi S; Tanaka S; Ueki K; Saito N J Neurosurg; 2018 May; 128(5):1428-1437. PubMed ID: 28753115 [TBL] [Abstract][Full Text] [Related]
24. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases. Miettinen M; Wang Z; Lasota J; Heery C; Schlom J; Palena C Am J Surg Pathol; 2015 Oct; 39(10):1305-12. PubMed ID: 26099010 [TBL] [Abstract][Full Text] [Related]
25. Chordoma: the entity. Yakkioui Y; van Overbeeke JJ; Santegoeds R; van Engeland M; Temel Y Biochim Biophys Acta; 2014 Dec; 1846(2):655-69. PubMed ID: 25193090 [TBL] [Abstract][Full Text] [Related]
26. SMARCB1/INI1 Involvement in Pediatric Chordoma: A Mutational and Immunohistochemical Analysis. Antonelli M; Raso A; Mascelli S; Gessi M; Nozza P; Coli A; Gardiman MP; Arcella A; Massimino M; Buttarelli FR; Giangaspero F Am J Surg Pathol; 2017 Jan; 41(1):56-61. PubMed ID: 27635948 [TBL] [Abstract][Full Text] [Related]
27. Multiple malignant tumors in a patient with familial chordoma, a case report. Sumransub N; Murugan P; Marette S; Clohisy DR; Skubitz KM BMC Med Genomics; 2021 Aug; 14(1):213. PubMed ID: 34465320 [TBL] [Abstract][Full Text] [Related]
28. Poorly differentiated SMARCB1/INI1-negative chordomas. Zhao J; Feng J; Chen L; Ma Y; Ding D; Wang H Clin Neuropathol; 2021; 40(1):36-45. PubMed ID: 32631481 [TBL] [Abstract][Full Text] [Related]
29. Base of skull chordomas in children and adolescents: a clinicopathologic study of 73 cases. Hoch BL; Nielsen GP; Liebsch NJ; Rosenberg AE Am J Surg Pathol; 2006 Jul; 30(7):811-8. PubMed ID: 16819322 [TBL] [Abstract][Full Text] [Related]
31. Poorly differentiated chordoma with whole-genome doubling evolving from a SMARCB1-deficient conventional chordoma: A case report. Curcio C; Cimera R; Aryeequaye R; Rao M; Fabbri N; Zhang Y; Hameed M Genes Chromosomes Cancer; 2021 Jan; 60(1):43-48. PubMed ID: 32920865 [TBL] [Abstract][Full Text] [Related]
32. From notochord formation to hereditary chordoma: the many roles of Brachyury. Nibu Y; José-Edwards DS; Di Gregorio A Biomed Res Int; 2013; 2013():826435. PubMed ID: 23662285 [TBL] [Abstract][Full Text] [Related]
33. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. Vujovic S; Henderson S; Presneau N; Odell E; Jacques TS; Tirabosco R; Boshoff C; Flanagan AM J Pathol; 2006 Jun; 209(2):157-65. PubMed ID: 16538613 [TBL] [Abstract][Full Text] [Related]
34. Brachyury expression in intracranial SMARCB1-deficient tumors: important points for distinguishing poorly differentiated chordoma from atypical teratoid/rhabdoid tumor. Kohashi K; Yamamoto H; Yamada Y; Kinoshita I; Oda Y Hum Pathol; 2021 Jun; 112():1-8. PubMed ID: 33741347 [TBL] [Abstract][Full Text] [Related]
35. Characterization of cancer stem-like cells in chordoma. Aydemir E; Bayrak OF; Sahin F; Atalay B; Kose GT; Ozen M; Sevli S; Dalan AB; Yalvac ME; Dogruluk T; Türe U J Neurosurg; 2012 Apr; 116(4):810-20. PubMed ID: 22283189 [TBL] [Abstract][Full Text] [Related]
36. MET overexpressing chordomas frequently exhibit polysomy of chromosome 7 but no MET activation through sarcoma-specific gene fusions. Grabellus F; Konik MJ; Worm K; Sheu SY; van de Nes JA; Bauer S; Paulus W; Egensperger R; Schmid KW Tumour Biol; 2010 Jun; 31(3):157-63. PubMed ID: 20512480 [TBL] [Abstract][Full Text] [Related]
37. Pediatric Chordoma: A Tale of Two Genomes. O'Halloran K; Hakimjavadi H; Bootwalla M; Ostrow D; Kerawala R; Cotter JA; Yellapantula V; Kaneva K; Wadhwani NR; Treece A; Foreman NK; Alexandrescu S; Velazquez Vega J; Biegel JA; Gai X Mol Cancer Res; 2024 Aug; 22(8):721-729. PubMed ID: 38691518 [TBL] [Abstract][Full Text] [Related]
38. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases. Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093 [TBL] [Abstract][Full Text] [Related]
39. Germline findings in cancer predisposing genes from a small cohort of chordoma patients. Raygada M; John L; Liu A; Schultz J; Thomas BJ; Bernstein D; Miettinen M; Raffeld M; Xi L; Tyagi M; Aldape K; Glod J; Reilly KM; Widemann BC; Wedekind MF J Cancer Res Clin Oncol; 2024 May; 150(5):227. PubMed ID: 38700789 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of the BMP4/SMAD signaling pathway in skull base chordomas is associated with poor prognosis. Feng Y; Zhang Q; Wang Z; Yan B; Wei W; Li P Int J Clin Exp Pathol; 2015; 8(7):8268-75. PubMed ID: 26339396 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]